COMMUNIQUÉS West-GlobeNewswire

Bone Therapeutics SA : Information relative au nombre total de droits de vote et d'actions
03/09/2018
Information réglementée Information relative au nombre total de droits de vote et d'actions Gosselies, Belgique, le 3 septembre 2018, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de [...]
Fashion Development Materials is born, the new Bio-on business unit dedicated to bioplastic materials for fashion and the luxury sector
03/09/2018
PRESS RELEASE Fashion Development Materials is born, the new Bio-on business unit dedicated to bioplastic materials for fashion and the luxury sector. FDM, Fashion Development Materials , is added to the 5 business [...]
Biocartis Group NV: Biocartis and Wondfo Announce Joint Venture for Commercialization of Idylla(TM) Platform in China
03/09/2018
PRESS RELEASE : REGULATED INFORMATION-INSIDE INFORMATION 3 September 2018, 07:00 CST/ 01:00 CEST Biocartis and Wondfo Announce Joint Venture for Commercialization of Idylla(TM) Platform in China Mechelen, Belgium, and [...]
Sorrento Therapeutics to Present at FB Riley and HC Wainwright Sept 2018 Healthcare Conferences in NYC (NY)
02/09/2018
SAN DIEGO, Sept. 02, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will be participating in upcoming investment healthcare [...]
Innovate Biopharmaceuticals Announces Participation at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City September 4-6, 2018
01/09/2018
RALEIGH, N.C., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/09/2018
CAMBRIDGE, Mass., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat [...]
Zenith Capital Closes $5.7 Million Private Placement
01/09/2018
This press release is not for dissemination in the United States or through US newswire services CALGARY, Alberta, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") today announced that [...]
Tetra Bio-Pharma Announces Record Date for Dividend-in-Kind of North Bud Farms Shares
31/08/2018
ORLEANS, Ontario, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSX VENTURE: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, [...]
Ortho Regenerative Technologies Inc. Announces CFO Change
31/08/2018
KIRKLAND, Quebec, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Ortho Regenerative Technologies Inc. ( CSE: ORTH ) (“ Ortho RTi ” or the “ Corporation” ) announces that Benedek (Ben) Simo has been appointed Interim Chief Financial [...]
Ascendis Pharma A/S Announces Upcoming Investor Presentations
31/08/2018
COPENHAGEN, Denmark, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today [...]
LeMaitre Vascular to Present at Upcoming Investor Conferences
31/08/2018
BURLINGTON, Mass., Aug. 31, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at the Wells Fargo Healthcare and RW Baird Healthcare conferences next week. George [...]
Exalenz Announces Second Quarter 2018 Financial Results
31/08/2018
Second quarter 2018 revenue increased 53% to $3.4 million, compared with $2.2 million in same period in 2017 The Company estimates total revenues for 2018 to reach $13 -14 million, an increase of 37 – 47% over 2017, and [...]
Olainfarm’s Six Months Net Profit Reaches 5,78 million euros
31/08/2018
Unaudited Consolidated Income Statement of AS Olainfarm for first six months of 2018 shows that the sales of the Group have reached 61.8 million euros, which represents a slight decrease of 1% compared to the same [...]
Oncology Venture A/S: Publication of financial report for January - June 2018
31/08/2018
Oncology Venture A/S ("Oncology Venture", formerly Medical Prognosis Institute A/S) hereby publishes the financial report for the period of January - June 2018. The report is available as an attached document to this [...]
Cytori Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
31/08/2018
Presentation on Thursday, September 06, 2018 at 09:10 AM Eastern Time SAN DIEGO, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that it will present at the 20 th Annual Rodman [...]
Oncology Venture A/S establish a flexible loan facility of up to SEK 40 million
31/08/2018
Oncology Venture A/S ("Oncology Venture", formerly Medical Prognosis Institute A/S) hereby announces that the company has entered into a flexible loan agreement with Trention AB. Under the terms of the agreement, [...]
Genmab Announces European Marketing Authorization for DARZALEX® (daratumumab) for Front Line Multiple Myeloma
31/08/2018
Company Announcement DARZALEX approved in Europe in combination with bortezomib, melphalan and prednisone in patients with newly diagnosed multiple myeloma Approval follows positive opinion by European Committee for [...]
Zynerba Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference
31/08/2018
DEVON, Pa., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Portola Pharmaceuticals Submits Prior Approval Supplement to U.S. FDA for Large-Scale Generation 2 Andexxa Process
31/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq:PTLA) today announced the submission of a prior approval supplement (PAS) to the U.S. Food and Drug Administration ( [...]

Pages